87 results
8-K
EX-10.1
PCSA
Processa Pharmaceuticals Inc
30 Jan 24
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
10:46am
prior to the date that this representation is made.
(j) Litigation. There is no action, suit, inquiry, notice of violation, proceeding … Stock Equivalents, (c) for the settlement of any outstanding litigation or (d) in violation of FCPA or OFAC regulations.
4.8 Indemnification
424B4
PCSA
Processa Pharmaceuticals Inc
29 Jan 24
Prospectus supplement with pricing info
4:15pm
and other intellectual property rights associated with our product candidates;
costs associated with prosecuting or defending any litigation that we … are or may become involved in and any damages payable by us that result from such litigation;
costs of operating as a public company;
the emergence
8-K
ilflrdj86
8 Aug 23
Processa Pharmaceuticals Appoints Life Sciences Industry Veteran George Ng as Chief Executive Officer
10:30am
8-K
EX-10.1
4jyppq78el1qt8g
24 Mar 22
Entry into a Material Definitive Agreement
4:30pm